Related Experiment Video
Updated: Aug 17, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Regulation of the proapoptotic factor FOXO1 (FKHR) in cardiomyocytes by growth factors and alpha1-adrenergic agonists
James B Morris1, Bronwyn Kenney, Huy Huynh
1Cellular Biochemistry Laboratory, Baker Heart Research Institute, PO Box 6492, St. Kilda Road Central, Melbourne 8009, Victoria, Australia.
Abstract:
Apoptotic responses in cardiomyocytes are opposed by the protein kinase Akt (protein kinase B) and thus can be suppressed by a number of growth factors and cytokines. In some cell types, Akt phosphorylates and inactivates members of the forkhead box (FOXO) family of transcription factors that are active in regulating the expression of proapoptotic cytokines and signaling intermediates. In the current study, we investigated the possibility that FOXO1 (FKHR) was expressed, regulated, and functional in cardiomyocytes. Addition of epidermal growth factor (EGF) (10 nM) to neonatal rat cardiomyocytes caused rapid phosphorylation of Akt and slower FOXO1 phosphorylation. In contrast, the alpha1-adrenergic receptor agonist phenylephrine (50 microM) did not phosphorylate Akt and caused dephosphorylation of FOXO1 acutely and increased FOXO1 expression with chronic exposure. Phenylephrine, but not EGF, caused nuclear translocation of FOXO1, a response that is associated with dephosphorylation. Overexpression of FOXO1 activated transcription of the proapoptotic cytokine, TNFalpha-related apoptosis-inducing ligand, as indicated by reporter gene activity. This response was enhanced by phenylephrine and inhibited by EGF. FOXO1 is expressed, regulated, and functionally active in cardiomyocytes and thus may contribute to apoptotic responses in heart.
Insights
Forkhead box protein 1 (FOXO1) is active in heart cells and can promote apoptosis. Phenylephrine increases FOXO1 expression and nuclear localization, enhancing its pro-apoptotic function in cardiomyocytes.
Area of Science:
- Cardiovascular Biology
- Molecular Cell Biology
- Signaling Pathways
Background:
- Cardiomyocyte apoptosis is regulated by protein kinase Akt, which can suppress cell death.
- Akt phosphorylates forkhead box (FOXO) transcription factors, inhibiting their pro-apoptotic activity.
- The role of FOXO1 in cardiomyocyte apoptosis was investigated.
Purpose of the Study:
- To determine if FOXO1 is expressed, regulated, and functional in cardiomyocytes.
- To investigate the effects of epidermal growth factor (EGF) and phenylephrine on FOXO1 activity.
- To understand FOXO1's contribution to cardiomyocyte apoptosis.
Main Methods:
- Neonatal rat cardiomyocytes were treated with EGF and phenylephrine.
- Akt and FOXO1 phosphorylation, expression, and subcellular localization were assessed.
- Reporter gene assays were used to measure FOXO1 transcriptional activity.
- FOXO1's role in apoptosis was evaluated.
Main Results:
- EGF rapidly phosphorylated Akt and slowly phosphorylated FOXO1.
- Phenylephrine did not phosphorylate Akt but caused FOXO1 dephosphorylation and increased its expression.
- Phenylephrine induced nuclear translocation of FOXO1, unlike EGF.
- Overexpressed FOXO1 activated the pro-apoptotic TNFalpha-related apoptosis-inducing ligand, an effect modulated by EGF and phenylephrine.
Conclusions:
- FOXO1 is expressed, regulated, and functionally active in cardiomyocytes.
- Phenylephrine promotes FOXO1 activity and nuclear localization, potentially increasing apoptosis.
- FOXO1 may play a significant role in mediating apoptotic responses in the heart.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
Regulation of the Unfolded Protein Response
TGF - β Signaling Pathway
The Extrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
